American Renal Associates Holdings Inc Revenue Growth Rates (ARA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
American Renal Associates Holdings Inc   (NYSE: ARA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ARA's Revenue Growth by Quarter and Year

American Renal Associates Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARA Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September 209.69
2nd Quarter June 205.15
1st Quarter March 193.18
FY 608.02





ARA Revenue third quarter 2020 Y/Y Growth Comment
American Renal Associates Holdings Inc reported decrease in Revenue in the third quarter 2020 by -0.82% to $ 209.69 millions, from the same quarter in 2019.
The decrease in the third quarter 2020 American Renal Associates Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.16%.

Looking into third quarter 2020 results within Healthcare Facilities industry 23 other companies have achieved higher Revenue growth. While American Renal Associates Holdings Inc ' s Revenue decline of -0.82% ranks overall at the positon no. 2050 in the third quarter 2020.


ARA Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December - 12.67 % -7.05 % -
3rd Quarter September -0.82 % 0.19 % 11.36 % -
2nd Quarter June -3.8 % -1.81 % 15.77 % -
1st Quarter March 0.74 % -1.49 % 8.98 % -
FY   - 2.08 % 7.08 % -

Financial Statements
American Renal Associates Holdings Inc 's third quarter 2020 Revenue $ 209.69 millions ARA's Income Statement
American Renal Associates Holdings Inc 's third quarter 2019 Revenue $ 211.43 millions Quarterly ARA's Income Statement


ARA Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December - -2.53 % -13.32 % 3.84 %
3rd Quarter September 2.21 % -0.85 % -2.84 % 1.01 %
2nd Quarter June 6.2 % 11.21 % 11.56 % 5.02 %
1st Quarter March -6.26 % 4.84 % -1.07 % -
FY (Year on Year)   - 2.08 % 7.08 % -


Back to ARA Growth rate Comparisons >> Back to ARA Growth rate Comparisons >>


Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #24
Healthcare Sector #368
Overall #2050

Revenue Y/Y Growth Statistics
High Average Low
15.77 % 3.16 % -7.05 %
(Jun 30 2018)   (Dec 31 2018)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #24
Healthcare Sector #368
Overall #2050
Revenue Y/Y Growth Statistics
High Average Low
15.77 % 3.16 % -7.05 %
(Jun 30 2018)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

American Renal Associates Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
11.56 % 1.36 % -13.32 %
(Jun 30 2018)  


ARA's III. Quarter Q/Q Revenue Comment
American Renal Associates Holdings Inc achieved in the III. Quarter 2020 above company average sequential Revenue growth of 2.21%, to $ 209.69 millions, from $205.15 millions in the second quarter.

Within Healthcare Facilities industry 41 other companies have achieved higher Revenue quarter on quarter growth. While American Renal Associates Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3193.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #42
Healthcare Sector #525
Overall #3193
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #42
Healthcare Sector #525
Overall #3193
Revenue Q/Q Growth Statistics
High Average Low
11.56 % 1.36 % -13.32 %
(Jun 30 2018)  


ARA's III. Quarter Q/Q Revenue Comment
American Renal Associates Holdings Inc achieved in the III. Quarter 2020 above company average sequential Revenue growth of 2.21%, to $ 209.69 millions, from $205.15 millions in the second quarter.

Within Healthcare Facilities industry 41 other companies have achieved higher Revenue quarter on quarter growth. While American Renal Associates Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3193.


American Renal Associates Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)
Cumulative Revenue 12 Months Ending $ 814.10 $ 815.84 $ 823.94 $ 822.52 $ 799.35
Y / Y Revenue Growth (TTM) 1.84 % 2.12 % 2.63 % 2.08 % -2.48 %
Year on Year Revenue Growth Overall Ranking # 1869 # 1141 # 1423 # 1555 # 1140
Seqeuential Revenue Change (TTM) -0.21 % -0.98 % 0.17 % 2.9 % 0.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 1644 # 1677 # 1421 # 913 # 1812


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2020 period, American Renal Associates Holdings Inc 's cumulative twelve months Revenue were $ 814 millions, company would post below average annual Revenue growth of 0.05% year on year, if the fiscal year would end at Sep 30 2020.
A slow-down in the American Renal Associates Holdings Inc 's Revenue growth from the 205.15% growth in Jun 30 2020.

In the Healthcare sector 302 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1141 to 1869.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 21
Healthcare Sector # 303
Overall # 1869

Revenue TTM Y/Y Growth Statistics
High Average Low
7.08 %
 2.23 %
-2.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 269
S&P 500 # 1644
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2020 period, American Renal Associates Holdings Inc 's cumulative twelve months Revenue were $ 814 millions, company would post below average annual Revenue growth of -2.48% year on year, if the fiscal year would end at Sep 30 2020.
A slow-down in the American Renal Associates Holdings Inc 's Revenue growth from the 205.15% growth in Jun 30 2020.

In the Healthcare sector 302 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1141 to 1869.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 21
Healthcare Sector # 303
Overall # 1869

Revenue TTM Y/Y Growth Statistics
High Average Low
7.08 %
2.23 %
-2.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 269
S&P 500 # 1644




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2020
Ensign Group Inc-0.21%$ -0.208 millions
Crh Medical Corporation-0.21%$ -0.215 millions
Radnet Inc -0.24%$ -0.237 millions
Tenet Healthcare Corp-0.24%$ -0.241 millions
Prestige Consumer Healthcare Inc -0.27%$ -0.272 millions
Establishment Labs Holdings Inc -0.42%$ -0.420 millions
Cocrystal Pharma Inc -0.61%$ -0.610 millions
American Renal Associates Holdings Inc -0.82%$ -0.823 millions
Rockwell Medical inc -0.83%$ -0.826 millions
Tactile Systems Technology Inc -1.05%$ -1.048 millions
Icon Plc-1.23%$ -1.226 millions
American Bio Medica Corporation-1.34%$ -1.341 millions
Transmedics Group Inc -1.58%$ -1.582 millions
Boston Scientific Corporation-1.77%$ -1.773 millions
Bruker Corporation-1.86%$ -1.861 millions
Orthofix Medical Inc -2.21%$ -2.215 millions
Encision Inc -2.29%$ -2.288 millions
Integra Lifesciences Holdings Corp-2.34%$ -2.338 millions
Neurometrix Inc -2.48%$ -2.480 millions
Lifevantage Corp-2.49%$ -2.492 millions
Macrogenics Inc -2.60%$ -2.604 millions
Surgalign Holdings Inc -2.70%$ -2.704 millions
Alimera Sciences Inc-2.93%$ -2.934 millions
Fortress Biotech Inc -3.04%$ -3.039 millions
Teleflex Incorporated-3.09%$ -3.088 millions
Adm Tronics Unlimited Inc -3.10%$ -3.105 millions
Bausch Health Companies Inc -3.21%$ -3.214 millions
Atricure Inc -3.28%$ -3.280 millions
Aspira Women s Health inc -3.58%$ -3.580 millions
Electromed Inc -3.59%$ -3.593 millions


About American Renal Associates Holdings Inc Revenue Growth Rates (ARA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.